VA
CVS icon

Valmark Advisers’s CVS Health CVS Stock Holding History

Valmark Advisers’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Buy
+2,014
New +$180K ﹤0.01% 715
2026
Q1 		– Sell
-3,592
Closed -$285K – 683
2025
Q4 		$285K Sell
3,592
-141
-4% -$11.1K ﹤0.01% 570
2025
Q3 		$281K Buy
3,733
+292
+8% +$20K ﹤0.01% 570
2025
Q2 		$237K Sell
3,441
-1,074
-24% -$70.4K ﹤0.01% 596
2025
Q1 		$306K Buy
+4,515
New +$270K ﹤0.01% 513
2024
Q4 		– Sell
-4,775
Closed -$300K – 596
2024
Q3 		$300K Sell
4,775
-310
-6% -$18.1K ﹤0.01% 501
2024
Q2 		$300K Sell
5,085
-386
-7% -$24.1K 0.01% 473
2024
Q1 		$436K Buy
5,471
+1,313
+32% +$100K 0.01% 401
2023
Q4 		$328K Sell
4,158
-656
-14% -$46.7K 0.01% 411
2023
Q3 		$336K Buy
4,814
+454
+10% +$32.2K 0.01% 384
2023
Q2 		$301K Sell
4,360
-55
-1% -$3.91K 0.01% 401
2023
Q1 		$328K Buy
4,415
+248
+6% +$20.8K 0.01% 379
2022
Q4 		$388K Buy
4,167
+289
+7% +$27.9K 0.01% 338
2022
Q3 		$370K Buy
3,878
+58
+2% +$5.74K 0.01% 319
2022
Q2 		$354K Buy
3,820
+1,071
+39% +$105K 0.01% 328
2022
Q1 		$278K Sell
2,749
-56
-2% -$5.88K ﹤0.01% 377
2021
Q4 		$289K Buy
2,805
+231
+9% +$21.3K 0.01% 353
2021
Q3 		$218K Sell
2,574
-286
-10% -$24K ﹤0.01% 370
2021
Q2 		$239K Buy
2,860
+184
+7% +$15.1K ﹤0.01% 357
2021
Q1 		$201K Buy
+2,676
New +$195K ﹤0.01% 367

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Valmark Advisers's CVS Position: Q2 2026 in Review

Valmark Advisers opened a new position in CVS Health (CVS) in Q2 2026: 2,014 shares worth $208K. The stake represents ﹤0.01% of the portfolio and ranks #715 among its holdings. This is a return to the name: Valmark Advisers previously reported a position in CVS as recently as Q4 2025.

Valmark Advisers first reported a position in CVS in Q1 2021 and has held it in 20 quarters since. The position peaked at $436K in Q1 2024. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Valmark Advisers held 2,014 shares of CVS Health worth $208K as of Q2 2026.
  • CVS Health was a new Valmark Advisers position in Q2 2026.
  • CVS Health made up ﹤0.01% of Valmark Advisers's portfolio in Q2 2026, its #715 holding.
  • Valmark Advisers first reported a position in CVS Health in Q1 2021 and has held it in 20 quarters since.
  • Valmark Advisers's CVS Health position peaked at $436K in Q1 2024.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Valmark Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.